IDiyas

For the Inventor, By the Inventor

Yongin-si, South Korea

Hyung-Chan Kim

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:

goldMedal14 out of 131,214 
 
Samsung Electronics Co., Ltd.
 patents

Years Active: 2012-2021

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 11155627 - Anti-c-Met/anti-Ang2 bispecific antibody (2021-10-26),
2. 10934350 - Humanized or affinity-matured anti ang-2 antibody and uses thereof (2021-03-02),
3. 10246511 - Fusion polypeptide capable of binding simultaneously to VEGF-C and VEGF-D (2019-04-02),
4. 10047154 - Angiopoietin-2 specific antibodies and uses thereof (2018-08-14),
5. 9994632 - Humanized or affinity-matured anti Ang-2 antibody and uses thereof (2018-06-12),
6. 9725513 - Fusion polypeptide inhibiting VEGF-C, VEGF-D and/or angiopoietin-2, and use thereof (2017-08-08),
7. 9637541 - Anti-C-Met/anti-Ang2 bispecific antibody (2017-05-02),
8. 9580497 - Antibody specifically binding to ANG2 and use thereof (2017-02-28),
9. 9527910 - Ang-2 specific antibodies and uses thereof (2016-12-27),
10. 9193768 - Peptide for inhibition of binding between angiopoietin-2 and integrin and use thereof (2015-11-24),
11. 8788304 - Digital rights management provision apparatus, system, and method (2014-07-22),
12. 8768849 - Digital rights management provision apparatus, system, and method (2014-07-01),
13. 8612355 - Digital rights management provision apparatus, system, and method (2013-12-17),
14. 8107090 - Image forming apparatus management server, service continuity score (SCS) calculating method of management server, and image forming apparatus management system (2012-01-31),

Title: The Innovative Contributions of Hyung-Chan Kim

Introduction

Hyung-Chan Kim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies for cancer treatment. With a total of 14 patents to his name, Kim's work is at the forefront of medical innovation.

Latest Patents

Among his latest patents is the "Anti-c-Met/anti-Ang2 bispecific antibody." This invention includes a composition that features the bispecific antibody and outlines a method for preventing and treating cancer by administering this antibody to patients. Another notable patent is the "Humanized or affinity-matured anti Ang-2 antibody and uses thereof." This invention focuses on an antibody that specifically binds to Angiopoietin-2, an angiogenesis-inducing factor, and describes methods for its application in medical treatments.

Career Highlights

Hyung-Chan Kim is currently employed at Samsung Electronics Co., Ltd., where he continues to push the boundaries of scientific research and innovation. His work has not only advanced the understanding of cancer therapies but has also contributed to the broader field of biotechnology.

Collaborations

Kim collaborates with esteemed colleagues, including Kyung Eun Kim and Sang Yeul Han, who share his commitment to advancing medical science through innovative research.

Conclusion

Hyung-Chan Kim's contributions to biotechnology and his impressive portfolio of patents highlight his role as a leading inventor in the field. His work continues to inspire advancements in cancer treatment and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…